-
公开(公告)号:US20100081792A1
公开(公告)日:2010-04-01
申请号:US11981821
申请日:2007-10-31
申请人: Steven Grant , Amrik Basran , Olga Ignatovich , Rudolph Maria T. De Wildt , Philip Jones , Neil Brewis , Ben Woolven , Elena De Angelis , Lucy J. Holt , Greg Winter , Ian Tomlinson , Kevin Moulder
发明人: Steven Grant , Amrik Basran , Olga Ignatovich , Rudolph Maria T. De Wildt , Philip Jones , Neil Brewis , Ben Woolven , Elena De Angelis , Lucy J. Holt , Greg Winter , Ian Tomlinson , Kevin Moulder
IPC分类号: C07K16/00
CPC分类号: C07K16/468 , A61K47/60 , A61K2039/505 , C07K14/415 , C07K16/18 , C07K16/22 , C07K16/241 , C07K16/2866 , C07K2317/21 , C07K2317/31 , C07K2317/34 , C07K2317/52 , C07K2317/522 , C07K2317/55 , C07K2317/569 , C07K2317/622 , C07K2319/00
摘要: The invention provides a dual-specific ligand comprising a first and second single variable domain, each having binding specificity for a antigenic target. The invention also provides for a single variable domain monomer ligand that specifically binds to an antigenic target.
摘要翻译: 本发明提供了双特异性配体,其包含第一和第二单可变结构域,每一结构域对抗原靶具有结合特异性。 本发明还提供了与抗原靶特异性结合的单个可变域单体配体。
-
公开(公告)号:US20060257406A1
公开(公告)日:2006-11-16
申请号:US11141661
申请日:2005-05-31
申请人: Greg Winter , Ian Tomlinson , Olga Ignatovich , Ben Woolven , Philip Jones
发明人: Greg Winter , Ian Tomlinson , Olga Ignatovich , Ben Woolven , Philip Jones
IPC分类号: A61K39/395 , C07H21/04
CPC分类号: C07K16/18 , A61K47/60 , A61K2039/505 , C07K16/241 , C07K16/2866 , C07K16/2878 , C07K16/40 , C07K2317/21 , C07K2317/31 , C07K2317/34 , C07K2317/55 , C07K2317/56 , C07K2317/569 , C07K2317/622 , C07K2317/92 , C12N2799/021
摘要: The invention provides a dual-specific ligand comprising a first immunoglobulin variable domain having a first binding specificity for a target ligand and a complementary or non-complementary immunoglobulin variable domain having a second binding specificity for a receptor of the target ligand.
摘要翻译: 本发明提供了双特异性配体,其包含对靶配体具有第一结合特异性的第一免疫球蛋白可变结构域和对靶配体的受体具有第二结合特异性的互补或非互补免疫球蛋白可变结构域。
-
公开(公告)号:US20060106203A1
公开(公告)日:2006-05-18
申请号:US11023959
申请日:2004-12-28
申请人: Greg Winter , Ian Tomlinson , Olga Ignatovich , Lucy Holt , Elena De Angelis , Philip Jones
发明人: Greg Winter , Ian Tomlinson , Olga Ignatovich , Lucy Holt , Elena De Angelis , Philip Jones
CPC分类号: C07K16/18 , C07K16/241 , C07K16/2875 , C07K16/2878 , C07K16/40 , C07K16/42 , C07K2317/21 , C07K2317/31 , C07K2317/34 , C07K2317/53 , C07K2317/55 , C07K2317/565 , C07K2317/567 , C07K2317/569 , C07K2317/622 , C07K2317/626 , C07K2317/92 , C07K2318/20
摘要: The invention provides a dual-specific ligand comprising a first immunoglobulin variable domain having a first binding specificity and a complementary or non-complementary immunoglobulin variable domain having a second binding specificity.
-
4.
公开(公告)号:US20110223168A1
公开(公告)日:2011-09-15
申请号:US13111516
申请日:2011-05-19
申请人: Greg Winter , Ian Tomlinson , Olga Ignatovich , Lucy Holt , Elena De Angelis
发明人: Greg Winter , Ian Tomlinson , Olga Ignatovich , Lucy Holt , Elena De Angelis
IPC分类号: A61K39/395 , C07K16/44 , A61P11/06 , A61P37/08
CPC分类号: C07K16/18 , A61K47/60 , A61K2039/505 , C07K16/241 , C07K16/2866 , C07K16/2878 , C07K16/40 , C07K2317/21 , C07K2317/31 , C07K2317/34 , C07K2317/55 , C07K2317/56 , C07K2317/569 , C07K2317/622 , C07K2317/92 , C12N2799/021
摘要: The invention provides a dual-specific ligand comprising a first immunoglobulin variable domain having a first binding specificity and a complementary or non-complementary immunoglobulin variable domain having a second binding specificity.
摘要翻译: 本发明提供了包含具有第一结合特异性的第一免疫球蛋白可变结构域和具有第二结合特异性的互补或非互补免疫球蛋白可变结构域的双重特异性配体。
-
公开(公告)号:US20060083747A1
公开(公告)日:2006-04-20
申请号:US11166496
申请日:2005-06-24
申请人: Gregory Winter , Ian Tomlinson , Olga Ignatovich , Neil Brewis
发明人: Gregory Winter , Ian Tomlinson , Olga Ignatovich , Neil Brewis
IPC分类号: A61K39/395 , C07H21/04 , C12P21/06 , C12N5/06 , C07K16/46
CPC分类号: C07K16/00 , A61K2039/505 , C07K16/241 , C07K16/40 , C07K2317/52 , C07K2317/569 , C07K2317/94 , C07K2319/00
摘要: The present invention relates to a simple method for generating antibody-based structures suitable for in vivo use. In particular, the invention relates to a method for the generation of antibody-based structures suitable for in vivo use comprising the steps of: (a) selecting an antibody single variable domain having an epitope binding specificity; and (b) attaching the single domain of step (a) to an effector group. Uses of molecules generated using the method of the Invention are also described.
摘要翻译: 本发明涉及一种生成适用于体内使用的基于抗体的结构的简单方法。 特别地,本发明涉及一种生成适合于体内应用的基于抗体的结构的方法,包括以下步骤:(a)选择具有表位结合特异性的抗体单可变结构域; 和(b)将步骤(a)的单一结构域连接到效应子组。 还描述了使用本发明的方法生成的分子的用途。
-
公开(公告)号:US20060280734A1
公开(公告)日:2006-12-14
申请号:US11165672
申请日:2005-06-24
申请人: Gregory Winter , Ian Tomlinson , Olga Ignatovich
发明人: Gregory Winter , Ian Tomlinson , Olga Ignatovich
IPC分类号: A61K39/395 , C07K16/44 , C07H21/04 , C12P21/06 , C12N5/06
CPC分类号: C07K16/005
摘要: The present invention relates to a method for the generation of immunoglobulin molecules of predetermined specificity. In particular, the invention relates to a method for the retargeting of the epitope binding specificity of one or more antibodies using single variable domains which exhibit a dominant epitope binding specificity.
摘要翻译: 本发明涉及产生具有预定特异性的免疫球蛋白分子的方法。 特别地,本发明涉及使用显示优势表位结合特异性的单个可变结构域重定向一种或多种抗体的表位结合特异性的方法。
-
公开(公告)号:US06846634B1
公开(公告)日:2005-01-25
申请号:US09511939
申请日:2000-02-24
申请人: Ian Tomlinson , Greg Winter
发明人: Ian Tomlinson , Greg Winter
IPC分类号: G01N33/50 , C07K1/04 , C07K14/705 , C07K14/725 , C07K16/00 , C12N15/09 , C12N15/10 , C12P21/08 , C40B30/04 , C40B40/02 , G01N33/15 , G01N33/68 , G01N33/53 , C07H21/04 , C12Q1/70
CPC分类号: C07K1/047 , C07K14/705 , C07K14/70503 , C07K14/7051 , C07K16/00 , C07K16/005 , C07K2317/21 , C07K2317/622 , C12N15/1037 , C40B30/04 , C40B40/02 , G01N33/6845 , G01N33/6854
摘要: The invention provides a method for selecting, from a repertoire of polypeptides, a population of functional polypeptides which bind a target ligand in a first binding site and a generic ligand in a second binding site, which generic ligand is capable of binding functional members of the repertoire regardless of target ligand specificity, comprising the steps of: a) contacting the repertoire with the generic ligand and selecting functional polypeptides bound thereto; and b) contacting the selected functional polypeptides with the target ligand and selecting a population of polypeptides which bind to the target ligand. The invention accordingly provides a method by which a polypeptide repertoire is preselected, according to functionality as determined by the ability to bind the generic ligand, and the subset of polypeptides obtained as a result of such preselection is then employed for further selection according to the ability to bind the target ligand.
摘要翻译: 本发明提供了从多肽的所有组成部分中选择结合第一结合位点中的靶配体和第二结合位点中的通用配体的功能性多肽群体的方法,该通用配体能够结合 包括以下步骤:a)使所述谱系与通用配体接触并选择与其结合的功能性多肽; 和b)使所选择的功能性多肽与靶配体接触并选择结合靶配体的多肽群体。 因此,本发明提供了根据通过结合通用配体的能力所确定的官能度来预先选择多肽集合的方法,然后根据能力进一步选择作为这种预选的结果的多肽获得的子集 以结合靶配体。
-
公开(公告)号:US06696245B2
公开(公告)日:2004-02-24
申请号:US09192854
申请日:1998-11-17
申请人: Greg Winter , Ian Tomlinson
发明人: Greg Winter , Ian Tomlinson
IPC分类号: C12Q170
CPC分类号: C07K1/047 , C07K14/705 , C07K14/70503 , C07K14/7051 , C07K16/00 , C07K16/005 , C07K2317/21 , C07K2317/622 , C12N15/1037 , C40B30/04 , C40B40/02 , G01N33/6845 , G01N33/6854
摘要: The invention provides a method for selecting, from a repertoire of polypeptides, a population of functional polypeptides which bind a target ligand in a first binding site and a generic ligand in a second binding site, which generic ligand is capable of binding functional members of the repertoire regardless of target ligand specificity, comprising the steps of: a) contacting the repertoire with the generic ligand and selecting functional polypeptides bound thereto; and b) contacting the selected functional polypeptides with the target ligand and selecting a population of polypeptides which bind to the target ligand. The invention accordingly provides a method by which a polypeptide repertoire is preselected, according to functionality as determined by the ability to bind the generic ligand, and the subset of polypeptides obtained as a result of such preselection is then employed for further selection according to the ability to bind the target ligand.
摘要翻译: 本发明提供了从多肽的所有组成部分中选择结合第一结合位点中的靶配体和第二结合位点中的通用配体的功能性多肽群体的方法,该通用配体能够结合 包括以下步骤:a)使所述谱系与通用配体接触并选择与其结合的功能性多肽; 和b)使所选择的功能性多肽与靶配体接触并选择结合靶配体的多肽群体。 因此,本发明提供了根据通过结合通用配体的能力确定的官能度来预先选择多肽集合的方法,然后根据该预选的能力进一步选择作为这种预选结果的多肽获得的子集 以结合靶配体。
-
公开(公告)号:US20090148434A1
公开(公告)日:2009-06-11
申请号:US12186281
申请日:2008-08-05
申请人: Ian Tomlinson , Amrik Basran , Philip Jones
发明人: Ian Tomlinson , Amrik Basran , Philip Jones
IPC分类号: A61K39/395 , C07K16/18
CPC分类号: C07K16/005 , A61K47/60 , A61K2039/505 , C07K16/18 , C07K16/241 , C07K16/2875 , C07K16/2878 , C07K16/40 , C07K16/468 , C07K2317/21 , C07K2317/31 , C07K2317/34 , C07K2317/56 , C07K2317/567 , C07K2317/569 , C07K2317/70 , C07K2317/76 , C07K2317/92 , C07K2317/94 , C07K2319/00
摘要: Provided are concentrated preparations comprising single immunoglobulin variable domain polypeptides that bind target antigen with high affinity and are soluble at high concentration, without aggregation or precipitation, providing, for example, for increased storage stability and the ability to administer higher therapeutic doses.
摘要翻译: 提供了包含单一免疫球蛋白可变结构域多肽的浓缩制剂,其以高亲和力结合靶抗原并且可以高浓度溶解,无聚集或沉淀,提供例如提高储存稳定性和施用较高治疗剂量的能力。
-
公开(公告)号:US20090082550A1
公开(公告)日:2009-03-26
申请号:US12186245
申请日:2008-08-05
申请人: Ian Tomlinson , Amrik Basran , Philip Jones
发明人: Ian Tomlinson , Amrik Basran , Philip Jones
IPC分类号: C07K16/18
CPC分类号: C07K16/005 , A61K47/60 , A61K2039/505 , C07K16/18 , C07K16/241 , C07K16/2875 , C07K16/2878 , C07K16/40 , C07K16/468 , C07K2317/21 , C07K2317/31 , C07K2317/34 , C07K2317/56 , C07K2317/567 , C07K2317/569 , C07K2317/70 , C07K2317/76 , C07K2317/92 , C07K2317/94 , C07K2319/00
摘要: Provided are concentrated preparations comprising single immunoglobulin variable domain polypeptides that bind target antigen with high affinity and are soluble at high concentration, without aggregation or precipitation, providing, for example, for increased storage stability and the ability to administer higher therapeutic doses.
摘要翻译: 提供了包含单一免疫球蛋白可变结构域多肽的浓缩制剂,其以高亲和力结合靶抗原并且可以高浓度溶解,无聚集或沉淀,提供例如提高储存稳定性和施用较高治疗剂量的能力。
-
-
-
-
-
-
-
-
-